

Tirzepatide
Dual GIP/GLP-1 receptor agonist. Superior weight loss efficacy with improved glycemic control in clinical trials.
Product Specifications
- CAS Number
- 2023788-19-2
- Catalog Purity
- ≥99.47%
- Form
- Lyophilized Powder
- Catalog Grade
- GMP
Product Details
Tirzepatide specifications
Use the product name, catalog reference and available specifications below when discussing your requirements with our team.
- Product
- Tirzepatide
- Catalog reference
- KERUIHK-0102
- CAS number
- 2023788-19-2
- Category
- Weight Loss & Metabolic
- Physical form
- Lyophilized Powder
Latest reported batch: Tirzepatide
Batch PB-2026-TIR-0849 · Oct 3, 2026
- Reported appearance
- White lyophilized powder
- Reported molecular weight / identity
- 4813.26 Da
- Analytical method
- RP-HPLC / MALDI-TOF
Reported analytical results
- HPLC Purity
- 99.19%Report specification: ≥98.0%
- Molecular Weight (MS)
- 4813.26 DaReport specification: 4813.47 ± 0.5 Da
- Amino Acid Analysis
- ConformsReport specification: Conforms to sequence
- Endotoxin (LAL)
- 0.26 EU/mgReport specification: < 1.0 EU/mg
Show 5 more test results
- Sterility (USP <71>)
- No growth observedReport specification: No evidence of microbial growth
- Residual Solvents
- < ICH Q3C limitsReport specification: ICH Q3C Class 2
- Optical Rotation
- -32.7 °Report specification: -30° to -35°
- Water Content (KF)
- 6.02%Report specification: ≤ 8.0%
- Peptide Content (AAA)
- 95.87%Report specification: ≥95.0%
Batch Documentation
Certificates of Analysis
Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.
Show 4 earlier reports
Product Inquiry
Request a Tirzepatide quotation
We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.



